(Trial) (No. 21, 2021)Date of issue: 20210308In order to further guide enterprises to carry out drug R & D and accelerate the process of R & D and listing of overseas-listed and domestic unlis
2021-03-10 vcc 20
In order to implement the relevant provisions of the regulations on the supervision and administration of cosmetics and the measures for the administration of registration and filing of cosmetics, and
2021-03-10 vcc 21
In order to further deepen the reform of the review and approval system of medical devices, according to the actual development and supervision of the medical device industry, and in accordance with t
2021-02-02 vcc 20
In order to strengthen the supervision and guidance of the registration of medical devices, and further improve the quality of the registration examination, the State Drug Administration has formulate
2021-02-02 vcc 16
In order to strengthen the supervision and guidance of the registration of medical devices and further improve the quality of registration examination, the State Drug Administration has formulated the
2021-02-02 vcc 16
In September 2018, the State Drug Administration issued the notice on publishing the newly revised catalogue of medical devices exempted from clinical trials (No. 94, 2018), comprehensively revised an
2021-02-02 vcc 10
As per the Opinions of the General Office of the CPC Central Committee and the General Office of the State Council on Deepening the Reform of Examination & Approval System to Encourage Innovation
2021-01-20 vcc 18